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Idiopathic CD4+ lymphocytopenia (ICL) is an extre-
mely rare syndrome characterized by a low CD4 cell
count less than 300  106/L or a CD4 count less than
20% on two or more measurements, without any
laboratory evidence of HIV infection or other under-
lying medical conditions.1 Patients suffering from
this syndrome are prone to develop opportunistic
infections. Pneumocystis carinii pneumonia, cryp-
tococcal meningitis, candidiasis and histoplasmosis
have been described in patients with ICL.1—5 The
optimal treatment for patients with ICL and oppor-
tunistic infections remains to be defined, as current
therapy is based only on case reports.1—7
A 75-year-old heterosexual white man presented
to the Department of Internal Medicine at the Uni-
versity Hospital Heraklion with severe headache and
fever and a four-month history of weight loss. The
patient had had a history of skin and central nervous
system (CNS) cryptococcal infection six years pre-
viously, which was treated with excision of the
lesion and flucytosine.
On admission, a lumbar puncture was performed
and Cryptococcus neoformans was isolated from the
cerebrospinal fluid (CSF) culture. A persistent lym-
phocytopenia (a systemic lymphocyte count of
approximately 500  106/L) was detected, with a
low CD4+ cell count of approximately 17  106/L,
combined with normal CD8 cell values.
A series of additional investigations was per-
formed in order to reveal any underlying disorder
resulting in compromised cell-mediated responses,
such as HIV infection, lymphoma, leukemia, or sar-
coidosis. The patient repeatedly tested negative for
HIV infection and no underlying disease was present
from the patient’s personal history. No pathological
findings were detected on computed tomographic1201-9712/$30.00 # 2005 International Society for Infectious Diseas
doi:10.1016/j.ijid.2004.12.003(CT) scans of the upper and lower abdomen or the
thorax. Gastroscopy and colonoscopy examinations
were also normal. A bone marrow biopsy revealed a
non-specific slightly hypoplastic bone marrow. The
cytology examination of the CSF was negative for
the existence of neoplastic cells. Furthermore, anti-
nuclear antibodies, antineutrophil cytoplasmic anti-
bodies, complement fragment 3, complement
fragment 4 and angiotensin converting enzyme tests
were also negative. The therapeutic regimen fol-
lowed was intravenous amphotericin B in combina-
tion with flucytosine for two weeks, followed by oral
fluconazole. Due to the underlying ICL, and the fact
that this was his second episode of CNS cryptococ-
cosis, the oral administration of fluconazole was
continued for life, combined with prophylaxis for
Pneumocystis carinii pneumonia (PCP).
Cryptococcal meningitis is the most frequent and
devastating fungal infection of the CNS in immuno-
compromised patients, mainly in hosts with
impaired cell-mediated immunity.5,6 Meningitis
can relapse even after successful therapy, as in this
patient, and recurrences seem to be caused by the
persistence of the original infecting strain.8 There
are few data regarding the clinical course, therapy
and outcome of cryptococcal meningitis in patients
with ICL. The optimal treatment of patients with ICL
and cryptococcal meningitis remains to be defined
and specific therapeutic recommendations are lack-
ing.1—4,7
In conclusion, in patients with cryptococcal
meningitis without HIV infection ICL, although
extremely rare, merits consideration and CD4+
counts should be part of the initial work up. Further-
more, it is thought to be reasonable to follow the
treatment recommendations for HIV-infected
patients with cryptococcal meningitis, and continue
fluconazole for life.5—7
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